Lumpectomy in Bangalore costs INR 75,000 to 2,00,000 at private specialist centres. Mastectomy runs INR 1,00,000 to 3,50,000 with modified radical mastectomy at the higher end. These figures cover surgery, anaesthesia, theatre and a two to four day hospital stay. Lumpectomy is the smaller operation but it always requires radiation afterward, which adds INR 90,000 to 3,50,000 to the total. Mastectomy costs more upfront but avoids mandatory radiation in many cases. The right choice between the two is never purely financial. It’s driven by tumour size, margin achievability and what the tumour board recommends for that specific case.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Lumpectomy and mastectomy produce equivalent survival in appropriately selected patients. The cost difference between them is real but it should never be the deciding factor. The oncological decision comes first.”

Lumpectomy is the less expensive operative procedure but the full treatment cost including mandatory radiation is higher than the surgical fee alone.

• Operative Cost: Lumpectomy at private specialist centres in Bangalore costs INR 75,000 to 2,00,000 covering the operation, anaesthesia, theatre charges and a two day hospital stay and breast cancer treatment at high-volume oncology centres like KIMS sits toward the upper end of that range.
• Radiation Is Mandatory: Every lumpectomy requires radiation to the remaining breast tissue and a complete course in Bangalore costs INR 90,000 to 3,50,000, making the total lumpectomy plus radiation cost INR 1,65,000 to 5,50,000 at private specialist centres.
• Sentinel Node Biopsy Added: Axillary staging through sentinel node biopsy runs in the same session at an additional INR 40,000 to 80,000 and the result directly determines whether adjuvant chemotherapy is added to the treatment plan after surgery.
• Oncoplastic Lumpectomy Premium: Oncoplastic techniques that reshape the breast at the time of tumour removal add a surgical premium of INR 30,000 to 80,000 over standard lumpectomy at centres with dedicated oncoplastic breast surgery capability in Bangalore.

Lumpectomy’s lower operative cost is partially offset by the mandatory radiation course that follows every breast-conserving procedure regardless of tumour biology or stage.

• Mastectomy Without Reconstruction: Simple or modified radical mastectomy at private specialist centres in Bangalore costs INR 1,00,000 to 3,50,000 covering surgery, anaesthesia, theatre and a three to five day hospital stay and robotic cancer surgery or conventional mastectomy packages at KIMS Hospital are quoted as all-inclusive figures before any procedure is booked.
• Reconstruction Adds Significantly: Immediate implant-based reconstruction adds INR 1,00,000 to 2,50,000 while flap reconstruction adds INR 2,00,000 to 5,00,000 on top of the mastectomy fee, making total mastectomy plus reconstruction cost INR 2 to 8.5 lakhs depending on technique.
• Post-Mastectomy Radiation at Stage 3: Mastectomy avoids radiation in most Stage 1 and 2 cases but Stage 3 disease requires post-mastectomy chest wall radiation regardless, adding the same INR 90,000 to 3,50,000 radiation cost to both procedures at locally advanced stages.
• Long-Term Cost Is Similar: When radiation after lumpectomy and reconstruction after mastectomy are both factored in, the total treatment cost difference between the two procedures at private specialist centres in Bangalore is smaller than the operative fee gap suggests.

The right operation is determined by oncological criteria not cost and for more on what qualifies a patient for breast conservation, our blog on breast conserving surgery covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to lumpectomy, mastectomy and oncoplastic breast surgery at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT and over 25 published clinical studies. Patients wanting a transparent cost breakdown alongside a clear surgical recommendation are seen here with every decision going through tumour board review. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Breast Cancer Surgery Options
2. Medijourney — Breast Cancer Treatment Cost Bangalore

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Pancreatic cancer is one of the hardest cancers to detect early because the pancreas sits deep in the abdomen and produces no reliable symptoms until the tumour is large or has spread. Most cases are diagnosed at Stage 3 or Stage 4. Early diagnosis happens in two specific situations: incidental detection on imaging ordered for another reason or systematic surveillance in patients with confirmed high-risk factors including hereditary pancreatitis, BRCA2 mutation, familial pancreatic cancer syndrome or longstanding Type 2 diabetes with unexplained weight loss.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Pancreatic cancer found early is surgically curable. The problem is the biology of the disease, not the surgery. Most patients don’t have symptoms until the window for curative resection has already closed.”

Early diagnosis relies on imaging, tumour markers and biopsy in combination rather than any single test used alone.

• CT Pancreas Protocol: A dedicated pancreatic phase CT scan is the primary imaging tool for identifying pancreatic tumours, assessing vascular involvement and staging resectability and pancreatic and bile duct cancer assessment at KIMS Hospital, Bangalore uses this as the first-line investigation for any suspected pancreatic lesion.
• Endoscopic Ultrasound: EUS provides higher resolution imaging of the pancreatic head, body and tail than CT alone and allows fine needle aspiration biopsy of lesions too small to sample by percutaneous route, making it essential for diagnosing small tumours and cystic lesions.
• CA 19-9 Tumour Marker: CA 19-9 is elevated in most pancreatic cancers but is not specific enough to use as a standalone screening test because it is also elevated in bile duct obstruction, pancreatitis and other benign conditions, making it most useful alongside imaging rather than alone.
• MRCP and PET Scan: MRCP defines ductal anatomy and identifies strictures or cystic lesions that may indicate early malignant change while PET-CT identifies metabolically active disease and confirms or excludes distant spread before any surgical decision is made.

A confirmed early-stage pancreatic tumour on imaging requires biopsy for histological diagnosis before any treatment plan is confirmed.

Systematic surveillance in high-risk individuals is currently the most clinically reliable pathway to early pancreatic cancer diagnosis.

• Hereditary Pancreatitis: Patients with confirmed hereditary pancreatitis have a 40 to 75 times higher lifetime risk of pancreatic cancer and annual EUS or MRI surveillance from age 40 is the clinical standard for this group, not a precautionary option.
• BRCA2 and PALB2 Mutations: Confirmed BRCA2 or PALB2 mutation carriers with a first-degree relative with pancreatic cancer are recommended annual EUS and MRI surveillance from age 50 or ten years before the youngest affected relative’s diagnosis age and robotic cancer surgery for resectable pancreatic lesions identified through surveillance produces significantly better outcomes than surgery for symptomatic disease.
• New Onset Diabetes Over 50: New-onset Type 2 diabetes in someone over 50 with unexplained weight loss and no family history of diabetes carries a clinically meaningful association with pancreatic cancer and warrants a dedicated pancreatic CT before attributing it to metabolic disease alone.
• Intraductal Papillary Mucinous Neoplasms: IPMNs detected incidentally on abdominal imaging are premalignant lesions that require structured surveillance with EUS or MRI every six to twelve months depending on size and morphology to detect malignant transformation before it becomes invasive.

Active surveillance in high-risk groups is where early pancreatic cancer diagnosis is actually achieved and for more on how cancer biopsy confirms diagnosis, our blog on cancer diagnosis covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to pancreatic cancer surgery including Whipple procedure, distal pancreatectomy and robotic-assisted resection at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with pancreatic lesions, incidental findings or high-risk surveillance needs are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Pancreatic Cancer Screening
2. World Health Organization — Cancer Early Detection

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Advanced breast cancer surgery in India costs INR 6 to 14 lakhs for Stage 3 disease covering surgery, chemotherapy, radiation and targeted therapy at private specialist centres. The same treatment in the USA starts at USD 40,000 and can exceed USD 1,25,000 for multimodal advanced cases. That is a cost difference of 60 to 80 percent for equivalent surgical technique, the same da Vinci robotic platform and comparable specialist training. The difference is structural, not clinical.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“The cost gap between India and the West is real and significant. What isn’t real is the assumption that lower cost means lower quality at specialist oncology centres. The comparison that matters is specialist centre to specialist centre, not country to country.”

Advanced breast cancer at Stage 3 requires a multimodal treatment plan and the cost reflects surgery plus the systemic treatment that surrounds it.

• Surgery Cost: Mastectomy with full axillary dissection at private specialist centres in Bangalore costs INR 1,50,000 to 3,50,000 and breast cancer treatment packages at KIMS Hospital covering surgery, anaesthesia, theatre and post-operative ward stay are quoted as all-inclusive figures before any procedure is booked.
• Neoadjuvant Chemotherapy: Most Stage 3 patients receive four to six cycles of chemotherapy before surgery at INR 20,000 to 1,00,000 per cycle depending on the regimen used, adding INR 1,20,000 to 6,00,000 to the total treatment cost before the operation even begins.
• Radiation After Mastectomy: Post-mastectomy chest wall radiation is standard for Stage 3 disease and a complete course costs INR 90,000 to 3,50,000 depending on the technique used with IMRT sitting at the upper end of that range.
• Targeted Therapy Cost: HER2 positive advanced breast cancer patients on trastuzumab face monthly drug costs of INR 50,000 to 1,00,000 for the full adjuvant course, making targeted therapy the largest single cost component for this subtype.

Total advanced breast cancer treatment in India runs INR 6 to 15 lakhs at private specialist centres compared to USD 40,000 to 1,25,000 for equivalent treatment in the USA.

• Same Platform, Lower Price: India’s top oncology centres use the same da Vinci robotic platform, the same FDA-approved implants and the same chemotherapy protocols as leading centres in the USA and UK and robotic cancer surgery for breast cancer at KIMS Hospital, Bangalore is performed on the same technology base as equivalent Western institutions.
• Waiting Time Advantage: NHS waiting times in the UK for breast cancer surgery can run six to twelve weeks from diagnosis. Indian specialist centres typically operate within one to three weeks of the surgical consultation, which matters clinically in aggressive subtypes where treatment delay affects outcomes.
• Follow-Up Is the Real Consideration: Patients who return home after treatment abroad need a structured handover plan to their local oncology team for the five to ten years of adjuvant hormone therapy and surveillance that follows advanced breast cancer surgery.
• Insurance Applies in Both Settings: Most Indian comprehensive health policies and international travel health plans cover cancer surgery at accredited Indian hospitals and patients should confirm cashless facility availability at the treating hospital before admission rather than relying on reimbursement.

The cost advantage of treatment in India over the USA and UK is real and consistent and for more on what to expect from cancer surgery at a specialist centre in Bangalore, our blog on cancer surgery in Bangalore covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to advanced breast cancer surgery including Stage 3 cases requiring neoadjuvant coordination, mastectomy with reconstruction and post-mastectomy radiation planning at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT and over 25 published clinical studies. International and out-of-state patients are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Breast Cancer Treatment by Stage
2. CarePal Secure — Breast Cancer Treatment Cost India 2025

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Breast cancer surgery in South India is best handled by a surgical oncologist with specialist oncology training, high operative volume, a full range of breast surgical techniques and a structured multidisciplinary tumour board review process for every case. At MACS Clinic in Jayanagar Bangalore, Prof. Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery, a fellowship in Laparoscopic and Robotic Onco-Surgery and originator credits for RABIT, MIND and RIA-MIND to breast cancer surgery across all stages and presentations.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“The best breast cancer surgeon for any patient is the one who offers the full range of surgical options, takes every case to tumour board and never plans an operation in isolation from the systemic treatment team.”

These are the things that set Dr. Nayak’s breast cancer surgical practice apart from most alternatives in South India:

• Specialist credentials: DNB in Surgical Oncology and General Surgery combined with a fellowship in Laparoscopic and Robotic Onco-Surgery completes the specialist training pathway that separates a dedicated surgical oncologist from a general surgeon performing breast operations, and that difference directly affects margin clearance rates, axillary staging accuracy and long term outcomes.
• Technique innovation: Originator of RABIT, MIND and RIA-MIND operative techniques refined through over 25 peer-reviewed clinical studies, representing a depth of clinical contribution to surgical oncology that most breast cancer surgeons operating in South India do not carry.
• High-volume tumour board: Every patient seen by Dr. Nayak goes through full multidisciplinary tumour board review with surgical oncology, medical oncology, radiation oncology and pathology all contributing before any operation is confirmed, ensuring no surgical decision is made without collective specialist input.
• Karnataka oncology leadership: Chairman of Oncology Services across Karnataka and Executive Director of Surgical Oncology at KIMS Hospital Bangalore, a leadership position that reflects clinical standing and the trust placed in his judgement across the most complex oncology cases in the state.

Patients from Chennai, Hyderabad, Kochi and Coimbatore seek consultation at MACS Clinic because the combination of specialist training, operative volume and full tumour board review is not consistently available at the same standard elsewhere in South India. Breast cancer treatment at MACS Clinic covers the full spectrum of breast cancer surgical options where every decision starts from what your specific case actually needs.

These are the breast cancer surgical approaches available at MACS Clinic under Dr. Nayak’s care:

• Lumpectomy: Breast conserving surgery that removes the tumour and a margin of surrounding tissue while preserving the rest of the breast, appropriate for early stage cancers where tumour size and location allow adequate margin clearance without full mastectomy.
• Mastectomy: Total removal of the breast for cases where tumour extent, multifocality or genetic risk makes breast conservation clinically inappropriate, performed with immediate or delayed reconstruction planning discussed before surgery rather than after.
• Oncoplastic surgery: Combines cancer removal with immediate breast reshaping in a single procedure, preserving cosmetic outcome without compromising oncological margins, appropriate for patients where standard lumpectomy alone would result in significant volume loss or deformity.
• Sentinel node biopsy and axillary dissection: Accurate axillary staging through sentinel node biopsy for clinically node-negative disease and full axillary dissection where nodal involvement is confirmed, both performed as part of the standard breast cancer surgical pathway at MACS Clinic.

Whether your specific breast cancer case requires conservative surgery, mastectomy, reconstruction or a combination depends on your tumour biology, staging and anatomy and that decision is made through tumour board review before surgery rather than at the time of the operation. Robotic cancer surgery at MACS Clinic covers the full minimally invasive spectrum where robotic-assisted approaches are offered for appropriate breast cancer cases.

Prof. Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery, a fellowship in Laparoscopic and Robotic Onco-Surgery and originator credits for RABIT, MIND and RIA-MIND to breast cancer surgery across all stages at MACS Clinic. He chairs Oncology Services across Karnataka and serves as Executive Director of Surgical Oncology at KIMS Hospital Bangalore with over 25 published clinical studies. Every breast cancer case goes through full multidisciplinary tumour board review before any surgical plan is confirmed. Call plus 91 9482202240 to book your consultation at MACS Clinic.

Reference Links-

1. National Cancer Institute. Choosing a Cancer Doctor. https://www.cancer.gov/about-cancer/managing-care/services
2. World Health Organisation. Breast Cancer Treatment. https://www.who.int/news-room/fact-sheets/detail/breast-cancer

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Most comprehensive health insurance policies in India cover cancer surgery including hospitalisation, surgeon fees, anaesthesia, theatre charges, chemotherapy and radiation therapy within the sum insured. Cancer-specific plans go further and offer lump-sum payouts on diagnosis in addition to treatment coverage. What actually gets paid depends on the sum insured, the waiting period clause, whether the hospital is on the insurer’s network and whether the specific treatment or drug is listed as covered under the policy terms.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Insurance confirmation before admission matters more than most patients realise. The time to check what is covered is before the surgery is scheduled, not after the bill arrives.”

Most comprehensive health policies and cancer-specific plans cover the core components of cancer surgical treatment within the stated sum insured limits.

• Surgery and Hospitalisation: Cancer surgery including lumpectomy, mastectomy, colectomy, robotic resection and HIPEC is covered under most comprehensive health policies and robotic cancer surgery at KIMS Hospital, Bangalore is included as a minimally invasive surgical procedure under most standard health insurance policies.
• Chemotherapy and Radiation: Pre-operative and post-operative chemotherapy and radiation therapy are covered under most plans including daycare chemotherapy sessions that don’t require overnight hospitalisation, though individual drug costs vary by policy.
• Diagnostic Tests: PET scan, CT scan, MRI, biopsy and tumour marker blood tests ordered as part of cancer staging and treatment monitoring are covered under most plans as diagnostic procedures linked to an active hospitalisation or treatment episode.
• Post-operative Follow-Up: Most comprehensive plans cover post-surgical follow-up consultations and surveillance scans within the policy period, though some plans cap follow-up coverage at a fixed number of visits or a fixed rupee amount per policy year.

Confirming what your specific policy covers before the first surgical consultation avoids billing surprises that arrive when the patient is least equipped to deal with them.

Several common exclusions catch patients off-guard and checking these before surgery is booked removes the risk of unexpected out-of-pocket costs.

• Waiting Period Exclusions: Most cancer insurance policies have an initial waiting period of 90 days during which no claims are accepted and breast cancer treatment or any other cancer surgery booked before this period ends will not be covered regardless of when the diagnosis was made.
• Pre-existing Cancer Exclusion: A cancer diagnosed before the policy was taken out is typically excluded from coverage or subject to a separate longer waiting period under most standard health insurance plans in India.
• Robotic Surgery Sub-limits: Some policies apply sub-limits specifically to robotic or laparoscopic surgery procedures and patients should confirm whether their policy covers the full robotic surgery cost or applies a conventional surgery rate to the claim.
• Targeted Therapy and Immunotherapy Drugs: Trastuzumab, pembrolizumab and other high-cost targeted or immunotherapy drugs are frequently excluded or sub-limited in standard health policies and require specific confirmation with the insurer before treatment begins rather than after the prescription is written.

Checking these four points with your insurer before the surgical consultation is scheduled prevents the financial surprises that derail treatment plans mid-course and for more on making informed cancer treatment decisions, our blog on second opinion in cancer diagnosis covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to cancer surgery across all types and stages at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting clarity on what their insurance covers before committing to a surgical plan are seen here with every decision going through tumour board review. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Cancer Treatment and Insurance
2. Star Health Insurance — Cancer Insurance Plans India

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Consultation fees for a surgical oncologist in Bangalore run between INR 500 and INR 1,500 at most private specialist centres depending on experience, hospital tier and whether it’s a first visit or a follow-up. Senior surgical oncologists with subspecialty training, high operative volumes and published research typically charge INR 1,000 to 1,500 per consultation. The consultation fee is just the starting point. What follows it, diagnostics, biopsy, surgery and adjuvant treatment, is where the real cost sits and understanding each component before the first appointment removes a significant amount of financial uncertainty from an already difficult situation.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“The first appointment should answer three things. What is it, what stage is it and what does the treatment plan look like from here. A clear answer to all three is what a surgical oncologist consultation should deliver, not a vague plan to run more tests.”

Fees vary by experience, hospital category and nature of the visit but the consultation cost is a small fraction of the total treatment cost for most cancer cases.

• Initial Consultation: First consultations at private specialist centres in Bangalore cost INR 500 to 1,500 with senior surgical oncologists at high-volume hospitals like KIMS at the upper end and general oncology clinics sitting at the lower end of that range.
• Follow-up Fees: Follow-up consultations typically cost INR 300 to 800 at most centres and minimally invasive cancer surgery specialists who run structured post-operative review programmes include follow-ups as part of a broader care package rather than billing each visit independently.
• Hospital vs Clinic: Consulting a surgical oncologist inside a multi-specialty private hospital adds an institutional registration fee of INR 200 to 500 on top of the consultation, whereas consulting at an independent oncology clinic like MACS typically has a cleaner single fee structure without additional registration charges.
• Telemedicine Fees: Video consultations with senior surgical oncologists in Bangalore run INR 500 to 1,000 and are particularly useful for out-of-state or international patients who want a specialist opinion before travelling to Bangalore for the operative consultation and surgery.

Consultation fees are transparent at most specialist centres in Bangalore and asking for the fee structure before booking removes any uncertainty about what the first appointment will cost.

The consultation opens the treatment plan. Several cost components follow it and patients who understand these upfront plan their finances with far less stress.

• Diagnostic Workup: Blood tests, biopsy, CT scan, PET scan and pathology together cost INR 15,000 to 60,000 depending on which tests the surgical oncologist orders at the first visit, and this diagnostic package is typically confirmed in full before any treatment is booked or priced.
• Surgical Fee: The surgeon’s operative fee sits separate from hospital and theatre charges in most private hospital billing structures in Bangalore and robotic cancer surgery or conventional oncological resection packages at KIMS Hospital are provided as all-inclusive quotes covering the surgical team, anaesthesia, theatre and post-operative ward stay.
• Tumour Board Fee: Some specialist oncology centres charge a nominal tumour board review fee of INR 500 to 1,000 for multidisciplinary case review but most high-volume oncology centres in Bangalore include this in the consultation or surgical package rather than billing it separately.
• Long-term Follow-Up: Cancer patients need surveillance imaging every three to six months for the first two to three years after surgery and budgeting INR 5,000 to 15,000 per review cycle for scans and consultation is realistic for structured oncological follow-up at a private specialist centre in Bangalore.

Understanding the full cost structure from consultation through to follow-up is what allows families to plan without financial surprises appearing mid-treatment and for more on choosing the right surgical oncologist in Bangalore, our blog on minimally invasive cancer surgery covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every surgical oncology consultation at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting a transparent consultation covering diagnosis, staging and a clear treatment plan are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. Practo — Surgical Oncologist Fees Bangalore
2. Credihealth — Best Surgical Oncologists Bangalore 2025

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.